187 related articles for article (PubMed ID: 32306543)
1. The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis.
Light A; Ahmed A; Dasgupta P; Elhage O
BJU Int; 2020 Jul; 126(1):26-54. PubMed ID: 32306543
[TBL] [Abstract][Full Text] [Related]
2. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of Urological Cancers.
Schulz WA; Sørensen KD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561442
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
5. The study of DNA methylation in urological cancer: present and future.
Andrés G; Ashour N; Sánchez-Chapado M; Ropero S; Angulo JC
Actas Urol Esp; 2013 Jun; 37(6):368-75. PubMed ID: 23643196
[TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic biomarkers in urological tumours.
Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
[TBL] [Abstract][Full Text] [Related]
7. Targeting molecular aberrations in urothelial carcinoma: are we almost there?
Apolo AB; Kwiatkowski DJ
Am Soc Clin Oncol Educ Book; 2013; ():195-9. PubMed ID: 23714499
[TBL] [Abstract][Full Text] [Related]
8. Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications.
Gerlinger M; Catto JW; Orntoft TF; Real FX; Zwarthoff EC; Swanton C
Eur Urol; 2015 Apr; 67(4):729-37. PubMed ID: 24836153
[TBL] [Abstract][Full Text] [Related]
9. New Progress of Epigenetic Biomarkers in Urological Cancer.
Wu P; Cao Z; Wu S
Dis Markers; 2016; 2016():9864047. PubMed ID: 27594736
[TBL] [Abstract][Full Text] [Related]
10. DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
Larsen LK; Lind GE; Guldberg P; Dahl C
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151158
[TBL] [Abstract][Full Text] [Related]
11. The role of methylation in urological tumours.
van der Heijden AG
Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of epigenetics in urological cancers.
Ramachandran K; Soloway MS; Singal R; Manoharan M
Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Immune system and Epigenetic Landscape of Urological Tumors.
Lobo J; Jerónimo C; Henrique R
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012885
[TBL] [Abstract][Full Text] [Related]
14. [High-throughput molecular analysis of urothelial carcinoma: potential clinical applications].
Todenhöfer T; Miernik A; Seiler R
Aktuelle Urol; 2019 Feb; 50(1):84-93. PubMed ID: 30731506
[TBL] [Abstract][Full Text] [Related]
15. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
[TBL] [Abstract][Full Text] [Related]
16. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
17. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
18. Evolving Role of Genomics in Genitourinary Neoplasms.
Devitt ME; Dreicer R
Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
[TBL] [Abstract][Full Text] [Related]
19. Pan-urologic cancer genomic subtypes that transcend tissue of origin.
Chen F; Zhang Y; Bossé D; Lalani AA; Hakimi AA; Hsieh JJ; Choueiri TK; Gibbons DL; Ittmann M; Creighton CJ
Nat Commun; 2017 Aug; 8(1):199. PubMed ID: 28775315
[TBL] [Abstract][Full Text] [Related]
20. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
